PUBLICATION

BMP Signaling Protects Telencephalic Fate by Repressing Eye Identity and Its Cxcr4-Dependent Morphogenesis

Authors
Bielen, H., and Houart, C.
ID
ZDB-PUB-121102-1
Date
2012
Source
Developmental Cell   23(4): 812-822 (Journal)
Registered Authors
Houart, Corinne
Keywords
none
MeSH Terms
  • Animals
  • Bone Morphogenetic Protein 2/deficiency
  • Bone Morphogenetic Protein 2/genetics
  • Bone Morphogenetic Protein 2/metabolism
  • Bone Morphogenetic Proteins/genetics
  • Bone Morphogenetic Proteins/metabolism*
  • Eye/cytology
  • Eye/embryology*
  • Eye/metabolism
  • Homeodomain Proteins/metabolism
  • Morphogenesis*
  • Mutation
  • Receptors, CXCR4/metabolism*
  • Signal Transduction*/genetics
  • Telencephalon/cytology
  • Telencephalon/embryology*
  • Telencephalon/metabolism
  • Zebrafish/embryology*
  • Zebrafish/metabolism
  • Zebrafish Proteins/deficiency
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/metabolism*
PubMed
23079599 Full text @ Dev. Cell
Abstract

Depletion of Wnt signaling is a major requirement for the induction of the anterior prosencephalon. However, the molecular events driving the differential regionalization of this area into eye-field and telencephalon fates are still unknown. Here we show that the BMP pathway is active in the anterior neural ectoderm during late blastula to early gastrula stage in zebrafish. Bmp2b mutants and mosaic loss-of-function experiments reveal that BMP acts as a repressor of eye-field fate through inhibition of its key transcription factor Rx3, thereby protecting the future telencephalon from acquiring eye identity. This BMP-driven mechanism initiates the establishment of the telencephalon prior to the involvement of Wnt antagonists from the anterior neural border. Furthermore, we demonstrate that Rx3 and BMP are respectively required to maintain and restrict the chemokine receptor cxcr4a, which in turn contributes to the morphogenetic separation of eye-field and telencephalic cells during early neurulation.

Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping